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INTRODUCTION:  Pancreatic  incidentalomas  are  diagnosed  at increased  rates  due  to advanced  pancreatic
imaging.  Coexistence  of such  lesions  with  another  pancreatic  pathology,  however,  is  uncommon  and
their  management  might  be  perplexed  by the  anatomical  location  and  the  histological  features  of  the
lesion.
PRESENTATION  OF  CASE:  A  patient  with  obstructive  jaundice  was  diagnosed  with  adenocarcinoma  of  the
pancreatic  head  and underwent  routine  pancreatic  imaging  (CT)  which  revealed  the  coexistence  of a  small
cystic  lesion  at  the  pancreatic  body.  Further  investigation  with  MRCP  and  ERCP  was  unable  to  conﬁrm  a
benign  lesion  and  total pancreatoduodenectomy  was  performed.  Histological  examination  showed  a  rare
type  of mixed  serous–mucinous  cystadenoma  of  borderline  malignancy  at the  pancreatic  body  coexistent
with  an  adenocarcinoma  of  the  pancreatic  head.
DISCUSSION: Coexistence  of a peripheral  pancreatic  cystic  tumor  with  a ductal  adenocarcinoma  of  the
pancreatic  head  is a very  rare  incidence  in medical  literature.  The  management  of  the  peripheral  lesion
is  not  straightforward  and  there  can  be uncertainty  as  to  the  extent  of  the  pancreatic  resection  that  may
be  required.
CONCLUSION:  Appropriate  preoperative  imaging  has  a signiﬁcant  impact  on the  deﬁnitive  management
of  synchronous  pancreatic  tumors.  Implications  of a common  pathogenetic  pathway  are  also  raised  for
this  rare  occurrence  of two  primary  epithelial  pancreatic  tumors.
gical .© 2012 Sur
. Introduction
Pancreatic tumors can be categorized into ductal and periph-
ral, depending on their origin within the pancreatic parenchyma.
eripheral cystic tumors do not communicate with the main
ancreatic duct (MPD) and include two main histological types:
erous cystadenoma/cystadenocarcinoma and mucinous cystade-
oma/cystadenocarcinoma. Differentiation of these cystic tumors
rom other benign peripheral cystic lesions, such as pancreatic
seudocysts, is important to determine their correct management.
arious combinations of investigations including CT, MRI  and trans-
bdominal ultrasound are often utilized. Endoscopic ultrasound
EUS) with ﬁne needle aspiration (FNA) and cyst ﬂuid sampling can
ometimes be helpful in making a deﬁnitive diagnosis.1
Synchronous primary pancreatic tumors are rare and reports
f various combinations of benign and malignant tumors of the
xocrine or endocrine pancreas have been published.2–5 Autopsy
tudies have reported an association between neoplastic cystic
esions or pancreatic adenocarcinoma and endocrine tumors of the
ancreas.4,6 Due to the relatively small number of cases, however,
athogenic pathways have not been yet elucidated and in most
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cases the coexistence of multiple pancreatic tumors is thought to
represent a distinct and possibly unrelated tumor growth.
We  encountered a case of pancreatic adenocarcinoma with a
synchronous peripheral lesion which could not be characterized
on preoperative imaging, posing a signiﬁcant diagnostic and ther-
apeutic dilemma. This case is of further interest because of the
coexistence of an extremely rare variant of a cystadenoma. The
coexistence per se has only rarely been reported and raises impor-
tant implications for possible common pathogenetic alterations.
2.  Presentation of case
A 53-year-old man  presented with anorexia, vomiting, yellow
discoloration of the skin and sclera and associated mild epigas-
tric pain with radiation to the right upper quadrant (RUQ) since
few days. The patient remained apyrexial and no previous med-
ical history was reported. On physical examination the patient
was jaundiced with mild tenderness at deep palpation of the epi-
gastrium and the RUQ. Laboratory examination revealed elevated
total (7.42 mg/dL) and conjugated (6.32 mg/dL) bilirubin levels in
serum along with a four to ﬁve fold increase in serum alkaline
phosphatase (1322 U/L) and -glutamyl transpeptidase (251 U/L)
Open access under CC BY-NC-ND licenselevels above normal. The cause of extrahepatic cholestasis was ini-
tially investigated with liver and biliary ultrasound scan which
conﬁrmed distension of the gallbladder and dilation of the com-
mon bile duct (CBD, d = 20.5 mm), the intrahepatic biliary tree and
BY-NC-ND license.
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Fig. 1. Synchronous pancreatic tumors. A solid mass at the pancreatic head (white
arrow) and a small hypodense cystic lesion at the lateral border of the pancreatic
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Fig. 2. Magnetic resonance cholangiopancreatography (MRCP) showing a dilated
main pancreatic duct in close relationship to the lesion of the pancreatic body, with-
F
pody  (yellow arrow) are visible on abdominal CT scan. (For interpretation of the
eferences to color in this ﬁgure legend, the reader is referred to the web  version of
his article.)
he main pancreatic duct (MPD, d = 5.6 mm),  excluding cholelithi-
sis or choledocholithiasis. Upper abdominal contrast-enhanced
omputed tomography (CT) revealed the presence of a mass at the
ancreatic head (Fig. 1, white arrow) and a small hypodense cystic
esion at the lateral border of the pancreatic body (Fig. 1, yellow
rrow), showing enhancement of thin septa within the lesion dur-
ng the distribution phase. In an effort to differentiate between a
eoplastic and a non-neoplastic cyst, a magnetic resonance cholan-
iopancreatography (MRCP) was conducted which showed marked
ilation of the MPD  in close relationship with the lesion (Fig. 2,
ellow arrow). Subsequent endoscopic retrograde cholangiopan-
reatography (ERCP) to deﬁne a possible communication between
he lesion and the MPD  was not feasible due to complete obstruc-
ion of the MPD  at the pancreatic head.
The patient underwent total pancreatoduodenectomy with
holedochojejunostomy and gastrojejunostomy. Histological
xamination of the surgical specimen showed two distinct epithe-
ial tumors: a pancreatic ductal adenocarcinoma (max. d = 2.7 cm)
ith variably sized tubular structures (Fig. 3a) at the pancreatic
ead and a mixed serous–mucinous cystadenoma (max. d = 1.3 cm)
f borderline malignancy (Fig. 3b) at the lateral border of the
ancreatic body without communication with the MPD.
.  DiscussionCystic tumors of the pancreas are often detected incidentally
pancreatic incidentalomas) owing to small size and asymptomatic
ourse. Differentiation of these tumors from other cystic lesions of
ig. 3. (a) Ductal adenocarcinoma of the pancreatic head with tubular structures (HE ×
ancreatic body (HE ×20; inset HE ×100).out excluding a possible communication between them. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web  version of
this article.)
the pancreas, such as pseudocysts, nonneoplastic true cysts and
cystic degeneration of solid tumors, is essential for proper follow-
up and management. Upper abdominal CT provides information
about the location, size, unilocular or multilocular structure and
relationship with the MPD. The latter is better investigated with
MRCP and/or ERCP which further distinguish between peripheral
tumors (absence of communication with the MPD) and ductal
tumors, i.e. intraductal papillary mucinous neoplasia.
Histological classiﬁcation of cystic pancreatic neoplasia has
been discussed by various authors and generally includes three
main types of neoplastic lesions: serous cystadenoma (SCA), muci-
nous cystadenoma (MCA) and intraductal papillary mucinous
neoplasia (IPMN) of either main pancreatic duct type or branch
duct type. SCA is considered a benign tumor arising from cen-
troacinar cells, does not communicate with the MPD  and carries
a very low malignant potential as opposed to mucinous cys-
tic neoplasms (MCNs) and IPMN. In our case, an extremely rare
type of mixed serous–mucinous cystadenoma of the pancreas was
detected.7 Moderate dysplastic changes of this borderline tumor
were attributed to the mucinous component. The presence of a
common developmental precursor of pancreatic epithelial cells
and associated oncogenic mutations might provide some evidence
for deviation from typical differentiation.8 Signiﬁcant implications
arise regarding the optimal management of small cystic pancreatic
tumors based on imaging studies alone. Current recommendations
dictate periodical follow-up with repeat imaging for SCA unless the
tumor becomes symptomatic and surgical resection for histologi-
cally documented MCA  and IPMN.9
20; inset HE ×100). (b) Borderline mixed serous–mucinous cystadenoma of the
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In our case, however, the operative strategy was  determined
y the presence of a synchronous ductal adenocarcinoma and
 standard pancreaticoduodenectomy (Whipple’s procedure) was
nitially planned. However, a safe pancreaticojejunostomy would
ot be possible due to the small distance of the cystic lesion from
he pancreatic neck, as seen on the CT scan. In this case, the anasto-
otic suture line would certainly interfere with the right border of
he cystic lesion, increasing the possibility of an anastomotic leak.
ased on these preoperative considerations, further investigation
y EUS-guided aspiration cytology was not deemed necessary as it
ould not change the operative plan. Thus a total pancreatectomy
as performed.
Coexistence of a peripheral pancreatic cystic tumor with a
ancreatic ductal adenocarcinoma is a very rare incidence in
edical literature.10,11 Despite the different histological origin of
hese neoplastic lesions, i.e. centroacinar cells and ductal cells
espectively, molecular analysis data have suggested that allelic
osses on chromosome 10q, observed in both pancreatic SCA
50% of cases) and ductal adenocarcinoma, might partly account
or synchronous development of these tumors at distinct sites
f the pancreas and exclude coincidental presentation in the
ame patient.12 Mutations of the phosphatase and tensin homolog
ene, a tumor suppressor gene located on 10q, have been impli-
ated in the development of both SCA and pancreatic ductal
denocarcinoma and might represent a common pathogenetic
athway.13 On the other hand, important genetic alterations com-
only found in pancreatic cancer, such as K-ras or p53 gene
utations, are absent in SCA.12 These data suggest a complex
equence of genetic events that lead to deviation from normal
ifferentiation of a common precursor of these lesions or the
resence of an underlying genetic defect that leads to the devel-
pment of distinct tumors of the exocrine pancreas. Moreover,
n our case emphasis is given on the occurrence of an extremely
are combination of a pancreatic ductal adenocarcinoma and a
ixed-type cystadenoma, which, to our knowledge, has no prece-
ent.
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